USD 0.04
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 6.43 Million USD | -42.57% |
2022 | 11.2 Million USD | 1901.13% |
2021 | 560.15 Thousand USD | -17.54% |
2020 | 679.26 Thousand USD | 294.09% |
2019 | 172.36 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 6.11 Million USD | 26.35% |
2024 Q1 | 4.84 Million USD | -24.78% |
2023 Q3 | 8.72 Million USD | -24.56% |
2023 FY | 6.43 Million USD | -42.57% |
2023 Q4 | 6.43 Million USD | -26.21% |
2023 Q2 | 11.56 Million USD | -6.79% |
2023 Q1 | 12.4 Million USD | 10.7% |
2022 Q2 | 3.9 Million USD | 229.2% |
2022 Q1 | 1.18 Million USD | 111.53% |
2022 FY | 11.2 Million USD | 1901.13% |
2022 Q4 | 11.2 Million USD | 130.94% |
2022 Q3 | 4.85 Million USD | 24.43% |
2021 FY | 560.15 Thousand USD | -17.54% |
2021 Q2 | 614.16 Thousand USD | 0.0% |
2021 Q4 | 560.15 Thousand USD | 10.0% |
2021 Q3 | 509.23 Thousand USD | -17.08% |
2021 Q1 | - USD | -100.0% |
2020 Q4 | 679.26 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 679.26 Thousand USD | 294.09% |
2019 FY | 172.36 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
BioQuest Corp. | 632.89 Thousand USD | -917.245% |
Clever Leaves Holdings Inc. | 7.02 Million USD | 8.367% |
Eagle Pharmaceuticals, Inc. | 172.6 Million USD | 96.27% |
Guardion Health Sciences, Inc. | 3.77 Million USD | -70.675% |
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 611.78 Thousand USD | -952.347% |
Instadose Pharma Corp. | - USD | -Infinity% |